BBIO vs UPS · rev $221.9M vs P/E 15, rev $88.66B
BridgeBio Pharma Inc (BBIO) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
BBIO currently screens at market cap $13.24B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the BBIO and UPS stock pages for the full models.
Not investment advice.